KOKO Business · 22 Nov 2026
China Expands Insurance Coverage for 107 New Drugs

China's national health authorities have expanded the basic insurance drug list by adding 107 new medications, effective from January 1, 2027. The updated catalog, released on Saturday, includes a total of 3,331 drugs, with 34 removed due to limited clinical value, better alternatives, or supply constraints.
The administration has been adjusting the insurance drug list annually for nine consecutive years, reflecting ongoing efforts to improve patient access to essential treatments. The revised list comprises 1,935 Western medicines and 1,396 traditional Chinese medicine products.
Among the newly added drugs, 31 are for tumors, 18 target rare diseases, and 24 address chronic conditions. The remaining entries cover areas such as infectious diseases and mental health, enhancing the range of treatments available through the insurance system.